Terms: = Head and neck cancer AND SALL4, ENSG00000101115, 57167, Q9UJQ4, ZNF797, MGC133050, HSAL4, DRRS, dJ1112F19_1 AND Prognosis
11844 results:
1. Prognostic and chemotherapeutic implications of a novel four-gene pyroptosis model in head and neck squamous cell carcinoma.
Yuan P; Jiang S; Wang Q; Wu Y; Jiang Y; Xu H; Jiang L; Luo X
PeerJ; 2024; 12():e17296. PubMed ID: 38756442
[TBL] [Abstract] [Full Text] [Related]
2. Exploration of lymph node recurrence patterns and delineation guidelines of radiation field in middle thoracic oesophageal carcinomas after radical surgery: a real-world study.
Du R; Fan S; Yang D; Wang X; Hou X; Zeng C; Guo D; Tian R; Jiang L; Dong X; Yu R; Yu H; Zhu S; Li J; Shi A
BMC Cancer; 2024 May; 24(1):596. PubMed ID: 38755542
[TBL] [Abstract] [Full Text] [Related]
3. Long-term prognosis after endoscopic submucosal dissection for esophageal cancer in older adult patients.
Konishi H; Urabe Y; Nakamura T; Ishibashi K; Mizuno J; Fukuhara M; Takasago T; Tanaka H; Tsuboi A; Yamashita K; Hiyama Y; Takigawa H; Kotachi T; Yuge R; Ishikawa A; Oka S
BMC Gastroenterol; 2024 May; 24(1):164. PubMed ID: 38745162
[TBL] [Abstract] [Full Text] [Related]
4. [The clinicopathological features of adult thyroid tumors with DICER1 mutation].
Tang J; Huang JJ; Luo YL; Zhang LK; Wang QQ; Chen J; Liu ZY
Zhonghua Yi Xue Za Zhi; 2024 May; 104(18):1623-1627. PubMed ID: 38742350
[TBL] [Abstract] [Full Text] [Related]
5. Multifactoral immune modulation potentiates durable remission in multiple models of aggressive malignancy.
Halpert MM; Burns BA; Rosario SR; Withers HG; Trivedi AJ; Hofferek CJ; Gephart BD; Wang H; Vazquez-Perez J; Amanya SB; Hyslop ST; Yang J; Kemnade JO; Sandulache VC; Konduri V; Decker WK
FASEB J; 2024 May; 38(10):e23644. PubMed ID: 38738472
[TBL] [Abstract] [Full Text] [Related]
6. WHO 2022 updates on follicular cell and c-cell derived thyroid neoplasm.
Goswami P; Patel T; Dave R; Singh G; Singh A; Kalonia T
J Med Life; 2024 Jan; 17(1):15-23. PubMed ID: 38737660
[TBL] [Abstract] [Full Text] [Related]
7. Triglyceride-inflammation score established on account of random survival forest for predicting survival in patients with nasopharyngeal carcinoma: a retrospective study.
Li J; Ye Y; Cai Y; Ji H; Qin W; Luo Y; Zhou X; Zhang Z; Xiao X; Zhang B
Front Immunol; 2024; 15():1375931. PubMed ID: 38736892
[TBL] [Abstract] [Full Text] [Related]
8. A nomogram based on nutritional and inflammatory parameters to predict DMFS and identify beneficiaries of adjuvant chemotherapy in IVA-stage nasopharyngeal carcinoma.
Pan Y; Chen Z; Hong W; Huang Z; Li Y; Cai S; Lai J; Lu J; Qiu S
BMC Cancer; 2024 May; 24(1):578. PubMed ID: 38734620
[TBL] [Abstract] [Full Text] [Related]
9. High incidence of lung cancer death after curative endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
Tajiri A; Tsujii Y; Nishida T; Inoue T; Maekawa A; Kitamura S; Yamaguchi S; Nishihara A; Yamada T; Ogiyama H; Murayama Y; Yamamoto S; Egawa S; Uema R; Yoshihara T; Hayashi Y; Takehara T
Cancer Med; 2024 May; 13(9):e7242. PubMed ID: 38733176
[TBL] [Abstract] [Full Text] [Related]
10. Minimal residual disease profiling predicts pathological complete response in esophageal squamous cell carcinoma.
Yue P; Bie F; Zhu J; Gao LR; Zhou Z; Bai G; Wang X; Zhao Z; Xiao ZF; Li Y; Zhou A; Liu WY; Jiao Y; Gao S
Mol Cancer; 2024 May; 23(1):96. PubMed ID: 38730415
[TBL] [Abstract] [Full Text] [Related]
11. m
Li S; Feng T; Liu Y; Yang Q; Song A; Wang S; Xie J; Zhang J; Yuan B; Sun Z
Int J Oral Sci; 2024 May; 16(1):36. PubMed ID: 38730256
[TBL] [Abstract] [Full Text] [Related]
12. A nomogram based on the SII3 and clinical indicators predicts survival in patients with nasopharyngeal carcinoma treated with PD-1 inhibitors.
Chen X; Liang W; Wu X; Wang Y; Hong Y; Xie M; Han R; Lin Z
Medicine (Baltimore); 2024 May; 103(19):e38017. PubMed ID: 38728499
[TBL] [Abstract] [Full Text] [Related]
13. Columnar Cell Thyroid Carcinoma: A Heterogeneous Entity Demonstrating Overlap Between Papillary Thyroid Carcinoma and Follicular Neoplasms.
Higgins KE; Sadow PM; Johnson DN; Wang P; Wanjari P; Cipriani NA
Head Neck Pathol; 2024 May; 18(1):39. PubMed ID: 38727854
[TBL] [Abstract] [Full Text] [Related]
14. A Competing Risk Nomogram for Prediction of prognosis in Patients With Primary Squamous Cell Thyroid Carcinoma.
Tian Y; He L; Zhang B; Deng L; Wang J
Technol Cancer Res Treat; 2024; 23():15330338241254059. PubMed ID: 38725285
[No Abstract] [Full Text] [Related]
15. CD276 regulates the immune escape of esophageal squamous cell carcinoma through CXCL1-CXCR2 induced NETs.
Xiong G; Chen Z; Liu Q; Peng F; Zhang C; Cheng M; Ling R; Chen S; Liang Y; Chen D; Zhou Q
J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38724465
[TBL] [Abstract] [Full Text] [Related]
16. Comparative analysis of the tumor microbiome, molecular profiles, and immune cell abundances by HPV status in mucosal head and neck cancers and their impact on survival.
Upadhyay R; Dhakal A; Wheeler C; Hoyd R; Jagjit Singh M; Karivedu V; Bhateja P; Bonomi M; Valentin S; Gamez ME; Konieczkowski DJ; Baliga S; Grecula JC; Blakaj DM; Gogineni E; Mitchell DL; Denko NC; Spakowicz D; Jhawar SR
Cancer Biol Ther; 2024 Dec; 25(1):2350249. PubMed ID: 38722731
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic value of postoperative anti-thyroglobulin antibody in patients with differentiated thyroid cancer.
Zhao Y; Mu Z; Liang D; Zhang T; Zhang X; Sun D; Sun Y; Liang J; Lin Y
Front Endocrinol (Lausanne); 2024; 15():1354426. PubMed ID: 38721144
[TBL] [Abstract] [Full Text] [Related]
18. Clinico-pathological study of esophageal mucoepidermoid carcinoma: a 10-year survival from a single center.
Wang Y; Wu Y; Zheng C; Li Q; Jiao W; Wang J; Xiao L; Pang Q; Zhang W; Wang J
BMC Gastroenterol; 2024 May; 24(1):156. PubMed ID: 38720257
[TBL] [Abstract] [Full Text] [Related]
19. CSC
Ortiz RC; Amôr NG; Saito LM; Santesso MR; Lopes NM; Buzo RF; Fonseca AC; Amaral-Silva GK; Moyses RA; Rodini CO
Sci Rep; 2024 May; 14(1):10583. PubMed ID: 38719848
[TBL] [Abstract] [Full Text] [Related]
20. [Auxiliary diagnosis and prognosis evaluation of KIF4A, RAD51AP1 and CDKN3 in esophageal cancer].
Qiu S; Guo CX; Li L; Yuan JF; Liu J; Peng YY; Qiu Q
Zhonghua Yu Fang Yi Xue Za Zhi; 2024 May; 58(5):665-672. PubMed ID: 38715507
[TBL] [Abstract] [Full Text] [Related]
[Next]
